Company profile
Celyad company profile
Celyad is a biopharmaceutical company, specialized in cell therapy. It develops technologies and treatments to treat severe diseases with poor prognosis. The company focuses on Immuno oncology, Cardiology, and Medical devices. Its main product candidates include CAR-T NKR-2, C-Cure. The firm has CYAD-01, CYAD-02, CYAD-03 programs in pipeline. The company owns trademarks and service marks including CELYAD, C-CATH, C_CURE, CATH and C-CATHez and CARDIO 3 BIOSCIENCES. The firm has Cardiology and Immuno-oncology operating segments.
Business identity
- Website
- http://www.celyad.com
- Contact email
- [email protected]
- Phone number
- +32(0) 10 39 41 00
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 11-50 employees
- Revenue range
- $0+
- Founded
- 2007-01-01, Year
Headquarters
- Headquarters
- Mont-Saint-Guibert, Wallonia, Belgium
- Postal code
- 1435
- Country code
- BE
- Continent
- Europe